Pharma Deals Review, Vol 2002, No 24 (2002)

Font Size:  Small  Medium  Large

OM Pharma to promote Gynazole-1 treatment in Latin America and Middle East

Business Review Editor

Abstract


KV Pharmaceutical signed an agreement with OM Pharma to market KV’s Gynazole-1® in Switzerland, 12 Latin American countries and 11 Middle Eastern countries. Gynazole-1 is a vaginal cream for treating vaginal yeast infections caused by Candida albicans.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.